Related Experiment Video
Updated: Dec 27, 2025

Establishment of a Co-culture System of Patient-Derived Colorectal Tumor Organoids and Tumor-Infiltrating Lymphocytes (TILs)
Published on: June 27, 2025
Targeting the Tumor Microenvironment in Colorectal Peritoneal Metastases
Wim Ceelen1, Robert G Ramsay2, Vignesh Narasimhan3
1Department of Human Structure and Repair, Ghent University, B-9000 Ghent, Belgium; Department of GI Surgery, Ghent University Hospital, Ghent, Belgium; Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.
Peritoneal metastasis (PM) in colorectal cancer (CRC) is poorly understood, limiting treatment efficacy. Research is exploring the tumor microenvironment (TME) and peritoneal ecosystem for new therapeutic targets.
Area of Science:
- Oncology
- Cancer Biology
- Gastroenterology
Background:
- Peritoneal metastasis (PM) affects approximately 25% of colorectal cancer (CRC) patients.
- The underlying pathophysiology of colorectal PM is not well understood.
- Current treatments like surgery and intraperitoneal chemotherapy have limited efficacy.
Purpose of the Study:
- To review recent insights into the tumor microenvironment (TME) of colorectal PM.
- To understand the peritoneal ecosystem in colorectal PM.
- To identify novel therapeutic targets for colorectal PM.
Main Methods:
- Literature review of recent studies on colorectal PM.
- Analysis of the structure and components of the TME in colorectal PM.
- Discussion of potential therapeutic strategies targeting the TME.
Main Results:
- Recent insights into the TME of colorectal PM have been reviewed.
- The role of the peritoneal ecosystem in PM progression is being investigated.
- Understanding the TME may lead to novel therapeutic approaches.
Conclusions:
- Further research into the TME and peritoneal ecosystem is crucial for understanding colorectal PM.
- Targeting the TME offers potential for novel therapeutic strategies.
- Re-engineering the pro-metastatic stroma could improve treatment outcomes for colorectal PM.
Related Concept Videos
The Tumor Microenvironment
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against...

